Rate of glycemic control and associated factors among type two diabetes mellitus patients in Ethiopia: A cross sectional study
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Objective: To assess the rate of glycemic control and associated factors among type 2 diabetes mellitus patients at Dilchora Referral Hospital, Dire Dawa, Eastern Ethiopia. Methods: A cross-sectional study was conducted from 13 May to 16 August 2019. Type 2 diabetic patients on follow up at Dilchora Referral Hospital who fulfilled the inclusion criteria of the study were included. Systematic random sampling was used to select study participants. Data was collected by a face-to-face interview and review of medical records. The primary outcome was the level of blood glucose during three consecutive visits. Poor glycemic control was defined as a blood sugar level of more than 154 mg/dL based on the average of measurements from three consecutive visits. Multivariate logistic regression analysis was used to identify determinants of glycemic control. Result: A total of 394 participants responded to the interview and were included in the final analysis. The overall prevalence of poor glycemic control was 45.2% (95%CI: 40.6%-50.0%). Patients who were on oral anti-diabetic drug plus insulin had more than two times greater chance of poor glycemic control than patients on oral anti-diabetic drug alone: 2.177(95%CI:1.10–4.29). The odds of poor glycemic control in patients who did not understand the pharmacist’s instructions was two times higher than patients with good understanding of instructions 1.86(95%CI: 1.10–3.13). Patients who had poor level of practice were found to have poor glycemic control: 1.69(95% CI: 1.13–2.55). Conclusion: The overall prevalence of poor glycemic control was high among type 2 diabetes patients. Oral anti-diabetic drugs in combination with insulin, lack of understanding of pharmacist’s advice, and poor practice of diabetic patients were significant factors of poor glycemic control. Pharmacists should reassure the understanding of patients before discharge during counseling. Optimization of the dose of antidiabetic medications and combination of oral hypoglycemic agents should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The included articles were published either in 2021 [16-22] or in 2020 [23-27]. No articles were published in 2022.”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“This systematic review included 12 articles that met the eligible criteria (Table 1) [16-27].”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Glycemic control was determined majorly based on HbA1C as reported in 10 studies [17-21,23-27], whereas only two studies considered glycemic control based on fasting blood glucose (FBG) [16,22].”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“The design of studies was commonly cross-sectional. There were 10 cross-sectional studies [16,18-25,27], whereas the remaining two studies were either retrospective observational [17] or retrospective [26].”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“The included 12 articles were from nine different countries: two studies from Ethiopia [16,22], two studies from Saudi Arabia [18,26], one study from Iraq [17], two studies from Indonesia [19,25], one study from Brazil [20], one study from Burkina Faso [21], one study from Morocco [23], one study from Eretria [24], and one study from Egypt [27].”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [20]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
WHO Global report on diabetes: A summary
Roglic, G. (2016) · International Journal of Noncommunicable Diseases · doi:10.4103/2468-8827.184853 · Cited by 998 · cited 1×
“Poor blood glucose control causes about 7% of deaths among men aged 20–69 and 8% among female [8].”
Background9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s009 · Cited by 972
Peyrot, M., Barnett, A. H., Meneghini, L. F., & Schumm‐Draeger, P. ‐. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03605.x · Cited by 655 · cited 1×
“Starting insulin therapy for T2DM patients often showed blood glucose level is not well controlled [41, 42].”
BackgroundFactors associated with poor glycemic control among patients with type 2 diabetes
Khattab, M., Khader, Y. S., Al-Khawaldeh, A., & Ajlouni, K. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.12.008 · Cited by 507 · cited 3×
“The finding is in line with prior research studies [20, 45] and contradicts the study conducted in India which reported no significant association between oral anti-diabetic drug plus insulin therapy with poor glycemic control [46].”
BackgroundResultIs Glycemic Control Improving in U.S. Adults?
Hoerger, T. J., Segel, J. E., Gregg, E. W., & Saaddine, J. B. (2008) · Diabetes Care · doi:10.2337/dc07-1572 · Cited by 477
Applied therapeutics; the clinical use of drugs
(1990) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(90)90630-5 · Cited by 399
Multifaceted Determinants for Achieving Glycemic Control
Chan, J. C. N., Gagliardino, J. J., Baik, S. H., Chantelot, J.-M., Ferreira, S. R. G., Hancu, N., Ilkova, H., Ramachandran, A., Aschner, P., & on behalf of the IDMPS Investigators (2009) · Diabetes Care · doi:10.2337/dc08-0435 · Cited by 291 · cited 1×
“4% of study participants had poor glycemic control [10].”
Background
Research works printed but not linked: 5
- Organization WH. Global data on visual impairments 2010. Geneva: World Health Organization Organization. 2012.
- Kassahun T, Eshetie T, Gesesew H. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: a cross-sectional survey in Ethiopia. BMC research notes. 2016; 9(1): 78. 10.1186/s13104-016-1896-7 26861243 PMC4748519 · DOI · Paper page
- Fiagbe J, Bosoka S, Opong J, Takramah W, Axame W, Owusu R, et al. Prevalence of controlled and uncontrolled diabetes mellitus and associated factors of controlled diabetes among diabetic adults in the hohoe municipality of Ghana. Diabetes Management. 2017; 7(5): 343– 54.
- Rasheed M, Islam N, Mahjabeen W. Factors Associated with Uncontrolled Type 2 Diabetes Mellitus. Journal of Islamabad Medical & Dental College (JIMDC). 2015; 4(2): 68– 71.
- Obied KA M TO. role of the pharmaceutical care in the management of patient with type 2 diabetes melitus international journal of pharmaceutical science. 2013; 4(4).
Cited by
Saher, T., Al-Worafi, Y. M., Iqbal, M. N., Wahid, A., Iqbal, Q., Khan, A., Atif, M., & Ahmad, N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.978345 · Cited by 370
Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review
Bin Rakhis, S. A., AlDuwayhis, N. M., Aleid, N., AlBarrak, A. N., & Aloraini, A. A. (2022) · Cureus · doi:10.7759/cureus.26180 · Cited by 152
Abera, R. G., Demesse, E. S., & Boko, W. D. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00974-z · Cited by 116
Lubaki, J.-P. F., Omole, O. B., & Francis, J. M. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00902-0 · Cited by 87
Bitew, Z. W., Alemu, A., Jember, D. A., Tadesse, E., Getaneh, F. B., Seid, A., & Weldeyonnes, M. (2023) · INQUIRY: The Journal of Health Care Organization, Provision, and Financing · doi:10.1177/00469580231155716 · Cited by 58
Shita, N. G., & Iyasu, A. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13673-5 · Cited by 49
Shiferaw, M., & Kassahun, W. D. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12267 · Cited by 51
“Patients' sex (n 1⁄4 10 studies) [21, 25, 29, 30, 31, 32, 33, 36, 37, 38] and age (n1⁄4 7 studies) [21, 25, 31, 32, 35, 37, 38] were found to be predictive of glycemic control among biologic variables.”
BackgroundTegegne, K. D., Gebeyehu, N. A., Tilahun, L., Yitayew, Y. A., & Kassaw, M. W. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1256024 · Cited by 40
Sendekie, A. K., Limenh, L. W., Bizuneh, G. K., Kasahun, A. E., Wondm, S. A., Tamene, F. B., Dagnew, E. M., Gete, K. Y., Kassaw, A. T., Dagnaw, A. D., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1488023 · Cited by 38
“In addition, existing studies have investigated factors associated with glycemic control in patients with diabetes, demonstrating relationships between sociodemographic, socioeconomic, clinical, and personal factors (38–43).”
Azagew, A. W., Mekonnen, C. K., Lambie, M., Shepherd, T. A., & Babatunde, O. O. (2025) · BMC Public Health · doi:10.1186/s12889-025-21828-y · Cited by 41
Mulugeta, T. K., & Hailu, D. (2022) · PeerJ · doi:10.7717/peerj.13797 · Cited by 27
Glycemic control and its influencing factors in type 2 diabetes patients in Anhui, China
Xing, X., Wang, X., Fang, X., Xu, J.-Q., Chen, Y.-J., Xu, W., Wang, H., Liu, Z., & Tao, S.-S. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.980966 · Cited by 26
Sahiledengle, B., Assefa, T., Negash, W., Tahir, A., Regasa, T., Tekalegn, Y., Mamo, A., Teferu, Z., Solomon, D., Gezahegn, H., et al. (2022) · Clinical ophthalmology · doi:10.2147/opth.s385806 · Cited by 24
Mengistu, M., & Benti, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267527 · Cited by 21
Tarekegn, E. T., Gobezie, M. Y., Haile, M. B., & Zerga, A. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-93739-2 · Cited by 24
“…result is consistent with similar studies conducted in sub-Saharan Africa, including Ghana, Tikur Anbessa Specialized Hospital (TASH), Mizan-Tepi, Dessie, Debre Markos, Dilchora Referral Hospital, and Metu, as well as systematic reviews from 2012 to 2022 in the region 6,13,27,31,34,36,38,42–44 .”
Wondm, S. A., Zeleke, T. K., Dagnew, S. B., Moges, T. A., Tarekegn, G. Y., Belachew, E. A., & Tamene, F. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-72981-0 · Cited by 22
Ali, S. Y., Seid, A. M., Hassen, K., Tadesse, S., Banjaw, Z., & Ibrahim, M. A. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073123 · Cited by 17
“20 In sub-Saharan countries, the costs of poor control of diabetes are 3–4 times higher than those with good glycaemic control.”
BackgroundShita, N. G., & Isayu, A. S. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01047-x · Cited by 16
“However, the proportion of uncontrolled levels of blood sugar in T2DM was far above the ground in Ethiopia [5–9].”
BackgroundGaredow, A. W., Tesfaye, G. T., Tamrat, R., & Wynendaele, E. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01795-y · Cited by 9
Adjei, S. K., Adjei, P., & Nkrumah, P. A. (2025) · Health Science Reports · doi:10.1002/hsr2.70558 · Cited by 11
“[24].”
Asrie, A. B., Belete, T. M., Misker, M. F., Beyna, A. T., Ayele, H. S., Tekle, K. G., Milikit, Y. Z., Andargie, E. A., Afework, H. T., Lenjiso, Y. G., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332628 · Cited by 13
“This result is comparable to that of a previous study in Ethiopia, which reported 45.2% poor glycemic control [41], and is higher than another study in the country, which reported 41.6% prevalence of poor glycemic control [42].”
InfluentialKiryowa, H. M., Munabi, I. G., Buwembo, W., Rwenyonyi, C. M., Kaddumukasa, M., & Mwaka, E. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.43.202.35971 · Cited by 6
“We opine that this may be related to the association between type of anti-diabetic medication and glycemic control [27,28].”
BackgroundDeterminants of Poor Glycemic Control Among Type 2 Diabetes Patients: A Systematic Review
Ahmed, Y., Abuelass, F. K. M., Abdelwahab, S. B. H., Mukhtar, M., Ahmed, Y., Elfahal, M., & Elhussein, N. S. M. (2025) · Cureus · doi:10.7759/cureus.82464 · Cited by 14
“…titration difficulties were noted, data on the proportion of insulin users or the adequacy of their training were not adequately provided, making it difficult to draw definitive conclusions on the impact of self-injection skills, as seen in studies by Nigussie et al. [18] and Traoré et al. [19].”
Li, H., Min, H., Zhang, L., Li, Y., Wang, J., & Jia, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1634768 · Cited by 14
Abukhalil, A. D., Muhanna, S. A., Madi, M., Al-Shami, N. A., Naseef, H., & Rabba, A. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s494951 · Cited by 4
Weng, Y., Miao, B., Hong, D., Zhang, M., Wang, B., Zhao, Q. D., & Wang, H. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072960 · Cited by 7
Lopes, A. C., Lourenço, O. M., Roque, F., & Morgado, M. (2023) · Biomedicines · doi:10.3390/biomedicines11020256 · Cited by 4
“These new drugs have allowed not only better glycemic control but also demonstrated protective effects in other concomitant pathologies that greatly contribute to the increase in morbidity and mortality rates in T2DM [16,17].”
BackgroundAkale, M., Tadesse, T., & Arega, B. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s441764 · Cited by 3
“18 However, it is higher than the study conducted in Eastern Ethiopia (45.2%), 19 and Qatar (35.5%).”
ResultInfluentialRoy, S., Malik, M., & Basu, S. (2024) · Cureus · doi:10.7759/cureus.72164 · Cited by 3
“The lack of integration of oral health with noncommunicable disease (NCD) programs in India precludes effective management of oral morbidities in the high-risk older adults having DM group [17,18].”
Rahman, M. M., Khan, M. S., Ikram, W., & Raza, M. (2025) · Cureus · doi:10.7759/cureus.87680 · Cited by 6
“Research supports the idea that more frequent, smaller meals help regulate glucose metabolism by preventing large postprandial glucose excursions [20,21].”
El-Hadidy, S. S., El‐Gilany, A., Badawi, M. R. A. G., & Elbialy, A. (2024) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.039.02.09 · Cited by 4
“17 - § Unmarried : single or widow or divorced, (r) constant not established.”
BackgroundMosleh, R., U’wais, A., Hamdan, A., Ghanim, M. A., & Jarrar, Y. B. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220523114806 · Cited by 5
Lubaki, J.-P. F., Omole, O. B., & Francis, J. M. (2022) · Research Square · doi:10.21203/rs.3.rs-1788561/v1 · Cited by 2
Tarif, B. S., & Alhillawi, Z. H. (2023) · Acta Chemica Iasi · doi:10.47743/achi-2023-1-0006 · Cited by 1
Tekalign, A. M., Lambero, H., & Motuma, A. (2025) · International Health · doi:10.1093/inthealth/ihaf024 · Cited by 3
“20 , 44 , 45 However, a study conducted at the Gondar University Hospital revealed a high proportion of poor glycaemic control in patients with diabetes for 7 y. 46 This is possibly due to reduced insulin secretion or excessive insulin resistance in those patients.”
Predictor factors of uncontrolled diabetes
Cheraghi, Z., Doosti‐Irani, A., Cheraghi, P., Mohammadi, P., & Otogara, M. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01906-3 · Cited by 3
Taherian, M. R., Etemad, K., Sadeghi, S., Jorjani, G., & Nazari, S. S. H. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/8029111 · Cited by 1
“Consistently, urban populations were observed to have better glycemic control, which aligns with evidence linking higher education levels and better awareness of diabetes to improved health outcomes, as reported by Nigussie et al. and Xing et al. [17, 18].”
Chen, J., Fu, G., Lei, X., Bai, C., Wen, L., & Zhang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1605008 · Cited by 2
Sawah, C. N., Ojong, E. W., Vigny, N. N., & Ngemenya, M. N. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i12.109233 · Cited by 2
Yimam, S., Muhye, A., Hassen, K., Tadesse, S., Banjaw, Z., & Ibrahim, M. A. (2023) · Research Square · doi:10.21203/rs.3.rs-2619268/v1 · Cited by 1
Dana, K., Kuhirunyaratn, P., Bunloet, A., Jindawong, B., & Prukpitikul, P. (2021) · Journal of Southwest Jiaotong University · doi:10.35741/issn.0258-2724.56.6.40 · Cited by 2
Glycaemic control and associated factors in adult patients with diabetes mellitus, South Sudan, 2021
Mogga, J. L. K., Loro, S., Gai, S., Anyit, M., Awu, R., Hadija, S., Aliti, J., Biriwo, L. S., & Ameh, D. (2023) · South Sudan Medical Journal · doi:10.4314/ssmj.v16i1.2
Sawah, C. N., Ojong, E. W., & Ngemenya, N. M. (2023) · Qeios · doi:10.32388/x0i9mv · Cited by 2
Mohammed, F. A., Ali, A. A., & Taye, T. A. (2024) · Research Square · doi:10.21203/rs.3.rs-3842861/v1
Zimamu, L. Y., Adal, G. M., Wubet, G. M., & Shiferaw, D. A. (2024) · Journal of Community Medicine and Health Solutions · doi:10.29328/journal.jcmhs.1001045
“Regarding factors associated with hypoglycemia, the (cid:976)indings of the current study were not consistent (cid:976)indings with other studies but the (cid:976)indings Bivariable were consistent with the multivariable (cid:976)indings from a similar study conducted in Ethiopia [31,32].”
Yabebal, Y., Genetu, A., & Wassie, G. T. (2024) · Research Square · doi:10.21203/rs.3.rs-4714071/v1
Abrahim, R. Y., Gudu, A., Abdi, D., Nuredin, K., Alemu, S., Azene, K., Lemma, B., & Getachew, O. (2025) · Science Frontiers · doi:10.11648/j.sf.20250603.12
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175640
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175646
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175643
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175637
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175634
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175655
Abera, R. G., Demesse, E. S., & Boko, W. D. (2022) · Figshare · doi:10.6084/m9.figshare.19314703
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175649
Abera, R. G., Demesse, E. S., & Boko, W. D. (2022) · Figshare · doi:10.6084/m9.figshare.19314700
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175652
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175658
Poor glycemic control among type II diabetes adult patients in Ethiopia: A systematic review
Alemayue, E. A., Jirata, D., & Mekonnen, S. A. (2025) · International Journal of Health & Allied Sciences · doi:10.4103/ijhas.ijhas_15_25
Metadata
- Authors
- Nigussie, S., Birhan, N., Amare, F., Mengistu, G., Adem, F., & Abegaz, T. M.
- Affiliations
- Haramaya University (ET)
- University of Gondar (ET)
- Wollo University (ET)
- University of South Australia (AU)
- Corresponding author
- Nigussie, Shambel
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-05-11
- Volume
- 16
- Issue
- 5
- Pages
- e0251506
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8112661
- OpenAlex
- W3163209275
- Cited by
- 62
- References
- 44
- Citations by year
- 2025: 15 · 2024: 10 · 2023: 8 · 2022: 28 · 2021: 1
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, glycemic control, poor glycemic control, blood glucose, oral antidiabetic drugs, insulin therapy, pharmacist counseling, patient adherence, risk factors, Ethiopia
- MeSH terms
- Glycemic Control, Adult, Aged, Blood Glucose, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Ethiopia, Female, Humans, Hyperlipidemias, Hypertension, Hypoglycemic Agents, Insulin, Male, Middle Aged, Patient Education as Topic, Pharmacists, Professional-Patient Relations, Risk Factors, Rural Population, Sampling Studies, Socioeconomic Factors, Urban Population, Comorbidity, Logistic Models, Comprehension, Medication Adherence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.